Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety of combining radiotherapy with immune-checkpoint inhibition
William L. Hwang, Luke Pike, Trevor J. Royce, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 8, pp. 477-494
Closed Access | Times Cited: 246

Showing 1-25 of 246 citing articles:

Smart cancer nanomedicine
Roy van der Meel, Einar Sulheim, Yang Shi, et al.
Nature Nanotechnology (2019) Vol. 14, Iss. 11, pp. 1007-1017
Open Access | Times Cited: 1025
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 835
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam, Sejin Son, Kyong Soo Park, et al.
Nature Reviews Materials (2019) Vol. 4, Iss. 6, pp. 398-414
Closed Access | Times Cited: 812
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 747
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl, Chien‐Huan Weng, Shabnam Eghbali, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 37-50
Closed Access | Times Cited: 585
Light‐Triggered In Situ Gelation to Enable Robust Photodynamic‐Immunotherapy by Repeated Stimulations
Zhouqi Meng, Xuanfang Zhou, Jun Xu, et al.
Advanced Materials (2019) Vol. 31, Iss. 24
Closed Access | Times Cited: 322
Time to abandon single-site irradiation for inducing abscopal effects
Eric D. Brooks, Joe Y. Chang
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 2, pp. 123-135
Closed Access | Times Cited: 276
Local biomaterials-assisted cancer immunotherapy to trigger systemic antitumor responses
Qian Chen, Muchao Chen, Zhuang Liu
Chemical Society Reviews (2019) Vol. 48, Iss. 22, pp. 5506-5526
Closed Access | Times Cited: 256
Programmed Cell Death Tunes Tumor Immunity
Jing Liu, Minjing Hong, Yijia Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 212
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
Tom van den Ende, Nicolien C. de Clercq, Mark I. van Berge Henegouwen, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 12, pp. 3351-3359
Open Access | Times Cited: 211
Assessing the interactions between radiotherapy and antitumour immunity
Clemens Grassberger, Susannah G. Ellsworth, Moses Q. Wilks, et al.
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 12, pp. 729-745
Closed Access | Times Cited: 207
Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
Liangrong Shi, Junjun Wang, Nianhua Ding, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 200
A Hybrid Eukaryotic–Prokaryotic Nanoplatform with Photothermal Modality for Enhanced Antitumor Vaccination
Qi Chen, Guojun Huang, Wangteng Wu, et al.
Advanced Materials (2020) Vol. 32, Iss. 16
Closed Access | Times Cited: 200
Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor Therapy
Gülşah Erel‐Akbaba, Litia Carvalho, Tian Tian, et al.
ACS Nano (2019) Vol. 13, Iss. 4, pp. 4028-4040
Open Access | Times Cited: 179
The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer
Stephanie L. Goff, David N. Danforth
Clinical Breast Cancer (2020) Vol. 21, Iss. 1, pp. e63-e73
Open Access | Times Cited: 153
Cancer Vaccines: Toward the Next Breakthrough in Cancer Immunotherapy
Yuka Igarashi, Tetsuro Sasada
Journal of Immunology Research (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 152
Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
Sepideh Mirzaei, Mohammad Gholami, Amirhossein Zabolian, et al.
Pharmacological Research (2021) Vol. 171, pp. 105759-105759
Closed Access | Times Cited: 137
PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
Qian Li, Jingjing Han, Yonglin Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 114
Nanoparticle-enhanced radiotherapy synergizes with PD-L1 blockade to limit post-surgical cancer recurrence and metastasis
Xin Guan, Liping Sun, Yuting Shen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 108
Cancer cell membrane camouflaged iridium complexes functionalized black-titanium nanoparticles for hierarchical-targeted synergistic NIR-II photothermal and sonodynamic therapy
Jinchao Shen, Johannes Karges, Kai Xiong, et al.
Biomaterials (2021) Vol. 275, pp. 120979-120979
Closed Access | Times Cited: 106
Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer
Yi Wang, Yuya Wang, Yifei Ren, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 542-565
Open Access | Times Cited: 103
Hot and cold tumors: Immunological features and the therapeutic strategies
Lianjie Wang, Hui Geng, Yujie Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 97
Immune Checkpoint Inhibition in GBM Primed with Radiation by Engineered Extracellular Vesicles
Tian Tian, Ruyu Liang, Gülşah Erel‐Akbaba, et al.
ACS Nano (2022) Vol. 16, Iss. 2, pp. 1940-1953
Open Access | Times Cited: 96
Reactive oxygen species-powered cancer immunotherapy: Current status and challenges
Mengying He, Mengyuan Wang, Tao Xu, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 623-648
Closed Access | Times Cited: 89
Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
Wenyao Zhen, Ralph R. Weichselbaum, Wenbin Lin
Advanced Materials (2022) Vol. 35, Iss. 21
Open Access | Times Cited: 88
Page 1 - Next Page

Scroll to top